Gavin Koh
Impact in
- Parasitology top 2%
- Vector-borne infectious diseases
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Vectors
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 16
- Burkholderia infections and melioidosis 12
- Mycobacterium research and diagnosis 3
-
- Tuberculosis Research and Epidemiology 6
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Sharon J. Peacock (12 shared papers)W. Joost Wiersinga (12 shared papers)Tom van der Poll (8 shared papers)Richard J. Maude (3 shared papers)Paul N. Newton (1 shared paper)Daniel H. Paris (1 shared paper)Stuart D. Blacksell (1 shared paper)Nicholas Day (12 shared papers)
- Journals
- PLoS neglected tropical diseases (5 papers)The Journal of Infectious Diseases (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Clinical Infectious Diseases (3 papers)PLoS ONE (2 papers)
- Partner nations
- United KingdomThailandUnited States
In The Last Decade
Gavin Koh
44 papers receiving 1.5k citations
Gavin Koh's Hit Papers
Peers
Comparison fields: 5 of 123
- Parasitology 187
- Infectious Diseases 412
- Epidemiology 449
- Public Health, Environmental and Occupational Health 244
- Immunology 141
Countries citing papers authored by Gavin Koh
This map shows the geographic impact of Gavin Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Koh more than expected).
Fields of papers citing papers by Gavin Koh
This network shows the impact of papers produced by Gavin Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Koh. The network helps show where Gavin Koh may publish in the future.
Co-authors
The 25 scholars most cited alongside Gavin Koh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 197 | |
| 2 | 2011 | 152 | |
| 3 | 2012 | 135 | |
| 4 | Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2022 | 130 |
| 5 | 2013 | 90 | |
| 6 | 2011 | 89 | |
| 7 | 2012 | 74 | |
| 8 | 2011 | 71 | |
| 9 | 2016 | 61 | |
| 10 | 2013 | 55 | |
| 11 | 2013 | 34 | |
| 12 | 2015 | 31 | |
| 13 | 2014 | 31 | |
| 14 | 2014 | 28 | |
| 15 | 2016 | 25 | |
| 16 | 2014 | 25 | |
| 17 | 2024 | 24 | |
| 18 | 2022 | 23 | |
| 19 | 2015 | 23 | |
| 20 | 2017 | 23 |
About Gavin Koh
Gavin Koh is a scholar working on Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Surgery and Molecular Biology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Burkholderia infections and melioidosis (12 papers), Malaria Research and Control (8 papers), Tuberculosis Research and Epidemiology (6 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mycobacterium research and diagnosis (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Parasitology (187 citations), Infectious Diseases (412 citations), Epidemiology (449 citations), Public Health, Environmental and Occupational Health (244 citations) and Immunology (141 citations). Gavin Koh has collaborated with scholars based in United Kingdom, Thailand and United States. Frequent co-authors include Sharon J. Peacock, W. Joost Wiersinga, Tom van der Poll, Richard J. Maude, Paul N. Newton, Daniel H. Paris, Stuart D. Blacksell, Nicholas Day, Direk Limmathurotsakul and Martin Dedicoat. Their work appears in journals such as PLoS neglected tropical diseases, The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.